SITC Clinical Practice Guideline Webinar – Immunotherapy for the Treatment of Acute Leukemia

When:  Jan 11, 2021 from 12:00 to 13:00 (ET)

18CIG-logo-rgb.jpg
On January 11, 2021 join leading experts in cancer immunotherapy as they present an overview of the recently published "The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immunotherapy for the Treatment of Acute Leukemia" during a live webinar.


This FREE CME-, CNE-, CPE-certified webinar is a chance for healthcare providers who treat cancer patients, including hematologists, oncologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants to learn about the recommendations from the published guideline on immunotherapy for the treatment of acute leukemia. 

 

This webinar will feature discussion of:

  • SITC's clinical practice guideline on immunotherapy for the treatment of acute leukemia
  • The optimal use of approved immunotherapies to improve outcomes for patients with ALL and AML
  • Recognition and management of common toxicities with immunotherapy
  • Emerging therapies for acute leukemia
  • Case studies on the use of immunotherapy for the treatment of acute leukemia

 

A dedicated question-and-answer session during the webinar will provide an opportunity for attendees to converse with the guideline expert panel members and ask questions about the CPG recommendations and their decision-making process for incorporating immunotherapy into treatment plans for the best possible outcomes their patients.

Webinar Faculty:

  • Moderator: Michael M. Boyiadzis, MD, MHSc – University of Pittsburgh (Expert Panel Chair)
  • Renier J. Brentjens, MD, PhD – Memorial Sloan-Kettering Cancer Center (Expert Panel Member)
  • Jorge M. Cortes, MD – Georgia Cancer Center (Expert Panel Member)
  • Mark R. Litzow, MD – Mayo Clinic Cancer Center (Expert Panel Member)

Webinar Agenda:

  • 12 – 12:05 p.m. ET  Overview: welcome and introductions
  • 12:05 – 12:45 p.m. ET  Presentation and discussion of guideline content from faculty experts
  • 12:45 – 12:55 p.m. ET  Question and answer session
  • 12:55 – 1 p.m. ET  Closing remarks


Click here to register for this webinar.


Continuing Education Credit Information:
Continuing Education Credits are available for physicians, nurses, and pharmacists. To view full accreditation information, click here.

Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer

This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.